Sorry, you need to enable JavaScript to visit this website.

A Study to Learn About the Safety of Single and Multiple Doses of PF-07275315 in Healthy Participants

A Phase 1, Randomized, Double-Blind, Sponsor Open, Placebo Controlled, Dose Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Intravenous and Subcutaneous Doses of PF-07275315 in Healthy Participants

Category & Conditions: Skin Diseases and Conditions
Medicine: PF-07275315
ClinicalTrials.gov Identifier (NCT): NCT05411588
Protocol ID: C4531001
Report Type: Final
Language: English

Open Plain Language Summary Result:

Click here